The Gastrointestinal (GI) Cancers Department offers highly specialized, multidisciplinary care for all tumors affecting the digestive tract, from the esophagus and stomach to the colon, rectum, and anus. Our integrated team of surgical, medical, and radiation oncologists is focused on combining curative intent with functional preservation. We utilize advanced technologies like Robotic Surgery, precision SBRT (Stereotactic Body Radiation Therapy), and molecularly tailored Immunotherapy to provide personalized treatment plans that strictly follow NCCN guidelines.
The GI tract is a complex pathway essential for life, extending from the esophagus to the anus. Cancers developing in these organs require a team approach due to the necessity of combining surgery with sophisticated drug and radiation therapies.
Comprehensive Cancer Management: We treat the full spectrum of GI malignancies, including Colorectal Cancer, Esophageal Cancer, Gastric (Stomach) Cancer, and Anal Cancer.
Integrated Team Approach: Our specialists—including GI Surgical Oncologists, Medical Oncologists, Radiation Oncologists, and Gastroenterologists—meet regularly in a dedicated Tumor Board to confirm the diagnosis, review advanced imaging, and map out a coordinated treatment plan that is often multimodal (using different therapies in sequence).
Functional Outcomes: We prioritize not only eradicating the tumor but also preserving vital digestive and elimination functions. For example, in rectal cancer, we aim to preserve the anal sphincter to avoid a permanent ostomy whenever possible.
Our services integrate the latest advancements in surgical robotics, targeted radiation, and molecularly guided drug therapies to improve both local control and long-term survival.
Utilizes Robotic-Assisted Surgery (e.g., for Colorectal Resections and Gastrectomy). The robotic platform provides the surgeon with enhanced 3D visualization, filtration of hand tremors, and instruments with 360-degree articulation, leading to superior precision and functional outcomes (like nerve sparing).
Keyhole Precision: We use the latest robotic surgical systems to remove tumors through very small incisions. This high level of precision means less pain, less blood loss, a shorter hospital stay, and a much faster return to normal life compared to traditional open surgery.
Utilizing chemotherapy and advanced radiation techniques (IMRT, IGRT) delivered before surgery (neoadjuvant) to shrink large tumors (especially in the esophagus and rectum) or as the sole primary curative treatment (e.g., for Anal Cancer) to preserve the organ.
Shrinking the Target: We often give you chemotherapy and focused radiation before the operation to make the tumor smaller and easier to remove completely. For Anal Cancer, this combination is often used to cure the disease without needing major surgery.
A highly specialized procedure for select patients with peritoneal surface malignancies (cancer spread lining the abdomen, often from colorectal or gastric origins). It combines aggressive surgical removal of tumors (CRS) with the direct application of heated chemotherapy (HIPEC) inside the abdominal cavity.
Heated Wash Therapy: For cancer cells that have spread to the lining of the abdomen, we surgically remove all visible tumors, then bathe the area with heated chemotherapy liquid to kill any remaining microscopic cells. Robotic-assisted HIPEC is an emerging option for select patients.
Systemic therapies are guided by molecular profiling of the tumor to identify specific mutations (e.g., MSI-H, RAS, BRAF). This allows for the selection of personalized drugs, including Targeted Agents (Biologics) and Immunotherapy (Checkpoint Inhibitors), which can double survival in metastatic disease.
Personalized Attack Plan: We test your cancer's DNA to find its unique weaknesses. We then use powerful, modern drugs—including Immunotherapy that harnesses your own immune system—to attack those specific weaknesses, leading to highly effective, individualized treatment.
Our surgeons are experts in high-volume, minimally invasive robotic resections, including Total Mesorectal Excision (TME) for rectal cancer, which minimizes nerve damage and preserves functional outcomes.
We specialize in technically demanding operations for Esophageal and Gastric cancers, with the expertise necessary for safe centralization of care, which is proven to improve survival rates in these complex diseases.
We utilize advanced SBRT (Stereotactic Body Radiation Therapy) for highly focused, high-dose treatment of localized tumors or liver/lung metastases, often sparing non-target GI organs.
Our therapeutic gastroenterologists perform advanced procedures, such as Endoscopic Ultrasound (EUS) for staging and internal biopsy, and endoscopic submucosal dissection/endoscopic mucosal resection for large polyps and early-stage cancers, often avoiding the need for surgery.
Recognizing the high impact of GI cancer and its treatment on a patient's nutrition and digestion, we integrate dedicated Oncology Nutritionists and Early Palliative Care Services from the time of diagnosis to maximize quality of life and treatment tolerance.
MBBS (2010), MD-General Medicine (2015), DM-Gastroenterology (2019)
Consultant
Gastroenterology